NCT01050309
An Open-label, Single-dose, Three Period Study to Determine the Pharmacokinetic Parameters of Hexaminolevulinate (HAL) Hydrochloride After Vaginal, Enema and Intravenous Administration of Healthy Female Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2009
Completion: Dec 31, 2009